Amarin Corporation PLC (AMRN NASDAQ) stock market data APIs
$12.1122
-0.21(-1.7%)
as of October 9, 2026
Try our APIs with
free plan!
Amarin Corporation PLC Financial Data Overview
Price chart is built with
Anychart
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Prev. Close
12.1122
Open
11.9014
High
12.3207
Low
11.8899
52 wk Range
11.8254-20.9
Market Cap
252 M
Shares Outstanding
20 969 K
Revenue
186 M
EPS
-0.07
Beta
0.768
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Amarin Corporation PLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Amarin Corporation PLC data using free add-ons & libraries
Get Amarin Corporation PLC Fundamental Data
Amarin Corporation PLC Fundamental data includes:
- Net Revenue: 186 M
- EBITDA: -21 095 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-07-29
- EPS/Forecast: -0.21
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Amarin Corporation PLC News
New
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
argenx SE ARGX announced positive top-line data from a phase II study evaluating FB102, an investigational therapy in adults with celiac disease. Celiac disease is a chronic autoimmune condition trig...
EDIT Set to Begin First-in-Human Study in Hypercholesterolemia
Editas Medicine EDIT announced that it has received approval to initiate the first-in-human phase I/II Strive clinical study of EDIT-401, its investigational in vivo gene-editing candidate for heteroz...
Viatris to Buy Pacira for $1.65B to Expand Non-Opioid Pain Portfolio
Viatris VTRS has entered into a definitive agreement to acquire Pacira BioSciences PCRX for $1.65 billion in cash. The deal is expected to expand VTRS' innovative medicines portfolio and strengthen it...
Here's Why You Should Add LPCN Stock to Your Portfolio Now
Lipocine LPCN is an emerging specialty pharmaceutical company focused on developing oral therapies for diseases with significant unmet medical needs. The company offers a mix of an approved commercial...
Get Amarin Corporation PLC fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.